Treatment and secondary prophylaxis of venous thromboembolism in cancer patients

This article was originally published here

Support Care Cancer. 2022 May 19. doi: 10.1007/s00520-022-07135-x. Online ahead of print.

ABSTRACT

Cancer-associated thrombosis (CAT) adversely affects the quality of life and survival of people with cancer. A holistic approach is optimal for the treatment and secondary prophylaxis of venous thromboembolism (VTE) including shared decision-making around anticoagulation, considering individual risk factors for VTE recurrence, morbidities from VTE, and resources available in cancer centres around the world. Taking a global perspective on availability and cost, this paper guides the reader through the wider aspects of treatment and secondary thromboprophylaxis which, in turn, influence the recent international guidelines.

PMID:35587290 | DOI:10.1007/s00520-022-07135-x